Tag - kidney disease

Kidney disease means your kidneys are damaged and can’t filter blood the way they should. Those with diabetes or high blood pressure are at greater risk of developing kidney disease.

Kidney problems include acute kidney injury, chronic kidney disease, kidney cysts, kidney stones, and kidney infections.

ISN around the world: Celebrating excellence and education at global events 

ISN leaders are spotlighting global kidney health in the Middle East in November and in North and East Asia, Western Europe, and South Asia throughout December, and celebrating two 2025 ISN Pioneer Award winners.  By sharing research, building partnerships, and amplifying regional voices, these engagements help advance the global conversation on equitable kidney care.   November 19th Congress of Asian Society of Transplantation (CAST 2025)    November 26-29, 2025                Zahra, Kuwait    November 28, Time TBD (Arabian Standard Time)   A highlight...

Welcoming new ISN Fellows, IN Scholars, and Clinical Research grantees  

From improving transplant outcomes to advancing clinical nephrology in local hospitals, the latest ISN Fellows, Interventional Nephrology (IN) Scholars, and Clinical Research Program grantees are already poised to make a difference in their communities. Through hands-on training, education, and innovative research, these professionals will gain the skills to strengthen worldwide kidney care where it’s...

ISN SGLT2i Toolkit now available in German and Spanish – French coming soon! 

Want quick, reliable references to guide multidisciplinary treatment decisions? The ISN Optimization of SGLT2i Therapy Toolkit provides handy infographics designed to help nephrologists, cardiologists, and other healthcare professionals optimize patient care across kidney, heart, and metabolic conditions.  Access the tools in English, German, and Spanish   Key topics covered include:  Nuts and bolts of SGLT2i therapy at the...

By young nephrologists, for young nephrologists: Research interpretation course now CME-accredited 

By YNC Chair Bianca Davidson  Do you sometimes feel unsure when reading clinical research papers or meta-analyses? You’re not alone — recent surveys show that one of the biggest challenges reported by young nephrologists was limited training in research interpretation.   That’s where the ISN Young Nephrologists Capacity Building Committee steps in. To support early-career professionals, the...

Sydney Tang, SPWG chair, on the global voices, groundbreaking science, and real-world impact of the WCN’26 scientific program

By bringing together experts from diverse regions and disciplines, the WCN’26 Scientific Program Working Group (SPWG) ensures that the World Congress of Nephrology (WCN) delivers scientific content that is of the highest quality and globally representative. We spoke with Sydney Tang, WCN’26 SPWG chair, to explore the many facets of next year’s scientific program,...

ISN Journal summaries on kidney transplantation in patients with plasma cell dyscrasia and gender differences in living kidney donation 

Kidney International®   Management recommendations for kidney transplantation in patients with plasma cell dyscrasia  Patients with plasma cell dyscrasia such as multiple myeloma and AL amyloidosis often develop kidney failure but have been underrepresented in kidney transplantation due to recurrence risk and poor outcomes. A multidisciplinary panel reviewed new evidence showing improved survival with modern therapies and expanding transplant eligibility....

Become a Fellow of the ISN: Recognition for long-term dedication  

 The Fellow of the ISN (FISN) status recognizes sustained dedication to the global kidney community and the ISN’s mission. It highlights a strong commitment to advancing kidney care, mentoring the next generation of nephrologists, and making a lasting impact on global kidney health   Awardees come from every corner of the globe — in 2025, 28% were from Western...

ISN Journal summaries on felzartamab for IgA nephropathy and a new anti-podocin ELISA  

Kidney International®   Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy  A phase 2a trial tested felzartamab, an anti-CD38 antibody, in 54 patients with IgA nephropathy. Patients received different doses of felzartamab or placebo over six months.   Felzartamab reduced protein in the urine, with the strongest and longest-lasting effect seen...

Encouraging government action in Tajikistan: Implementing the ISN Dialysis Framework 

    The deputy minister of health and staff from the Health Department, Tajikistan, visit a new hemodialysis center opened with support from the ISN SRC Program   Irma Tchokhonelidze observed significant gaps in dialysis provision during her 2021 visits to kidney centers in Dushanbe, including limited diagnostic capacity, the absence of patient registries, and inconsistent follow-up...

ISN International Expert Forum: Harnessing multidisciplinary insight for better CKM outcomes 

In October, 77 leading experts gathered in Amsterdam for the “ISN International Expert Forum: Exploring the Nexus of Cardio-Kidney-Metabolic Health,” a multidisciplinary meeting dedicated to shaping the future of cardio-kidney-metabolic (CKM) care.   Over one and a half days of dynamic discussion, participants explored ways to overcome barriers in care delivery, strengthen health system integration,...

HRH Prince Daniel of Sweden meets ISN Immediate Past-President, Masaomi Nangaku, in Japan to champion global kidney health 

On October 14, 2025, His Royal Highness Prince Daniel of Sweden visited ISN Immediate Past-President Masaomi Nangaku at the University of Tokyo Graduate School of Medicine. A kidney transplant recipient and patron of the ISN, Prince Daniel has long been an advocate for kidney disease awareness. They discussed ISN initiatives, including the Global Kidney Health...

ISN Train-the-Trainer Program for pregnancy and kidney disease comes full circle as former trainees join the faculty 

A new cohort of trainees has been accepted into the program and will receive guidance from members of the inaugural cohort, now serving as faculty alongside senior mentors.   The ISN Train-the-Trainer program in pregnancy and kidney diseases, led by Shilpa Jesudason (Australia) and Michelle Hladunewich (Canada), aims to build a robust network of professionals...

The power of polypills: Rethinking CKD therapy — a WCN’26 plenary with Anthony Rodgers  

Anthony Rodgers has led the development of a groundbreaking and affordable four-in-one cardiovascular "polypill" and directed major clinical trial programs in both developed and developing countries. At WCN'26, he will deliver the plenary lecture, "The potential of polypills in CKD," exploring how polypills could simplify therapies, improve adherence, and reduce cardiovascular risk in people...

ISN Journal summaries on the DIALIZE-Outcomes trial and heat stress nephropathy in CKDu hotspots in India 

Kidney International®   The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis  People on hemodialysis often face dangerous swings in blood potassium that can trigger sudden death or heart rhythm problems.   The DIALIZE-Outcomes trial tested whether the potassium binder sodium zirconium cyclosilicate (SZC) could reduce serious cardiovascular events compared with placebo in 2,690 patients with kidney failure.  The...

From page to stage: Apply for a 2025 KI-ISN Early-Career Researcher Award 

Was your original research published in Kidney International® in 2025?   Here’s a chance to have your work showcased at the World Congress of Nephrology 2026 in Yokohama, Japan — and receive $500!   Find out more and apply by December 5   Who can apply for a KI-ISN Early-Career Researcher Award?     First authors of original research papers (clinical or basic/translational...

Build an early CKD detection program, one building block at a time 

Early detection of CKD can save lives and reduce healthcare costs by slowing progression, preventing complications, and avoiding costly dialysis or transplantation. Utilize the Starting and Sustaining Early CKD Detection and Intervention Programs Toolbox to address CKD detection gaps rand help improve care for those at risk.  Designed as a set of building blocks, the...

“Straightforward to detect and treat”: Marcello Tonelli on preventing kidney disease — watch the recording

"Kidney disease is straightforward to detect and straightforward to treat in primary care, if you provide people with the right tools and the right support." That was the message from ISN President Marcello Tonelli during "Kidney Health Matters: Advancing Commitments into Action," a high-level event co-hosted by the ISN and Devex on the sidelines...

ISN around the world: Celebrating excellence and education 

ISN leaders are spotlighting global kidney health throughout October. Whether sharing the latest research, building partnerships, or amplifying regional voices, these engagements help elevate the global conversation on equitable kidney care.  Where to find the ISN this October  October 7-10   10th Annual Congress of the SFNDT Touraine, France  At the congress of the Société Francophone de Néphrologie, Dialyse...

New at WCN’26: Courses now included in the congress registration fee!* 

The WCN'26 program on Saturday, March 28, 2026, offers interactive courses designed to sharpen skills, deepen knowledge, and enhance patient care.     Explore WCN’26 courses  Register for WCN'26 at early bird rates  Submit your abstract    Cancer and Kidney Disease: The Growing Intersection of Their Genesis and Treatment Gain an up-to-date overview of onco-nephrology through expert-led, case-based sessions. This clinically focused...

Early-career nephrologists deepen expertise in glomerular disease at ISN course in Prague  

As part of its commitment to strengthening global kidney care, the ISN hosted its latest “Primer Course in Glomerular Diseases” in Prague, Czech Republic, in September 2025.  One participant commented, “It was fun, interesting, and relevant to daily clinical practice. I have definitely gained more confidence in the diagnosis and management of glomerular diseases.”  Over two...